TriangleNCT00381680 · OUTCOME
Adjusted Event Free Survival
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- adjusted percentage of participants
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 3 years
What was measured
Adjusted percentage of patients who were event free at 3 years. For patients who received matched donor SCT, EFS was adjusted to start from the actual SCT date. For patients who did not undergo SCT, EFS was adjusted to start from median time to SCT based on patients who received matched related SCT (where patients who had events prior to SCT date were excluded from the calculation of median time to SCT).
Analysis population: The analysis is limited to eligible patients on Standard VCR dosing who received matched related SCT, excluding patients who had events prior to receiving SCT. And those patients on Regimen A who did not undergo SCT, excluding patients who went off therapy prior to the adjusted starting time.
Groups in this outcome
Regimen A: Standard Vincristine Dosing
Standard VCR dosing (1.5 mg/m\^2, max 2 mg)
| Group | Source count |
|---|---|
| Regimen A: Standard Vincristine Dosing | 152 |
Reported measurements
Received SCT
| Group | Source count |
|---|---|
| Regimen A: Standard Vincristine Dosing | 34 |
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Regimen A: Standard Vincristine Dosing | 82.2 | Not reported | 68.8 | 95.5 | Not reported |
Did not receive SCT
| Group | Source count |
|---|---|
| Regimen A: Standard Vincristine Dosing | 118 |
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Regimen A: Standard Vincristine Dosing | 64.2 | Not reported | 55.3 | 73.1 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 68.8
- upper Limit
- 95.5
- value
- 82.2
- denoms
- counts
- group Id
- OG000
- value
- 34
- units
- Participants
- title
- Received SCT
- categories
- measurements
- group Id
- OG000
- lower Limit
- 55.3
- upper Limit
- 73.1
- value
- 64.2
- denoms
- counts
- group Id
- OG000
- value
- 118
- units
- Participants
- title
- Did not receive SCT
- denoms
- counts
- group Id
- OG000
- value
- 152
- units
- Participants
- description
- Adjusted percentage of patients who were event free at 3 years. For patients who received matched donor SCT, EFS was adjusted to start from the actual SCT date. For patients who did not undergo SCT, EFS was adjusted to start from median time to SCT based on patients who received matched related SCT (where patients who had events prior to SCT date were excluded from the calculation of median time to SCT).
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Standard VCR dosing (1.5 mg/m\^2, max 2 mg)
- id
- OG000
- title
- Regimen A: Standard Vincristine Dosing
- param Type
- NUMBER
- population Description
- The analysis is limited to eligible patients on Standard VCR dosing who received matched related SCT, excluding patients who had events prior to receiving SCT. And those patients on Regimen A who did not undergo SCT, excluding patients who went off therapy prior to the adjusted starting time.
- reporting Status
- POSTED
- time Frame
- 3 years
- title
- Adjusted Event Free Survival
- type
- SECONDARY
- unit Of Measure
- adjusted percentage of participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice